Physician

Vincent D Abbrescia, D.O

According to 2025 Medicare claims, Vincent Abbrescia, D.O (NPI: 1821077462) practices cardiology in the Dover, DE market, with the plurality of this provider's patient population coming from Kent, DE. This provider's primary affiliated billing organization is BAYHEALTH MEDICAL CENTER, INC (NPI: 1285809509; TIN: 510064318) and primary practice location at 19904-3490. Abbrescia is affiliated with the eBrightHealth ACO (ACO ID: A3053), participating under the MSSP model.

Abbrescia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,829 traditional Medicare patients, billed 7,095 HCPCS/CPT codes, and received $360,779 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,050 prescription claims across 531 beneficiaries totaling $750,962 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 14 claims. Open Payments data shows 11 records totaling $133. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $448,212 to $750,962. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,612	10,240	$557,752
2016	2,506	10,529	$587,513
2017	2,643	9,842	$542,341
2018	2,430	9,135	$519,810
2019	2,066	8,210	$501,058
2020	2,087	6,728	$418,832
2021	2,288	7,395	$460,479
2022	1,984	6,789	$435,979
2023	1,966	6,863	$411,376
2024	1,829	7,095	$360,779

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	419	3,413	$448,212
2016	441	3,754	$483,070
2017	449	3,863	$407,070
2018	470	4,264	$453,045
2019	499	4,025	$524,342
2020	504	3,810	$500,638
2021	495	3,458	$527,248
2022	503	3,617	$655,504
2023	508	3,898	$746,805
2024	531	4,050	$750,962

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	25	$50,616
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	15	$29,748
2021	N/R	14	$26,321
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	390	393	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	417	597	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	604	982	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	651	1,111	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	560	689	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	306	22,169	$417,728
Entresto	Sacubitril/Valsartan	61	3,540	$76,805
Xarelto	Rivaroxaban	73	4,029	$70,470
Brilinta	Ticagrelor	24	2,075	$28,409
Repatha Sureclick	Evolocumab	19	1,014	$18,764

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$133	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vincent D. Abbrescia, D.O?

Tedicare shows public-source Medicare data for Vincent D. Abbrescia, D.O (NPI 1821077462), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vincent D. Abbrescia, D.O have ACO affiliation data?

Vincent D. Abbrescia, D.O is shown with ACO affiliation data for eBrightHealth ACO (MSSP, ACO ID A3053).

What billing organization is linked to Vincent D. Abbrescia, D.O?

Vincent D. Abbrescia, D.O is linked to BAYHEALTH MEDICAL CENTER, INC (billing NPI 1285809509) in the available physician profile data.

Does Vincent D. Abbrescia, D.O have Open Payments data?

Vincent D. Abbrescia, D.O has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.